Display search results for ** instead (14 products)

Showing 1-10 of 14

Given the importance of the changes from PPACA and the creation of the health insurance marketplaces, we are providing our online Frost.com blog on HIX in collected form for the month of September for ease of use by our subscription clients. This discussion is brought to you by our Connected Health research program. Please also follow our blog, par...

USD 450.00

USD 337.50 save 25 %

This issue of Vital Signs, released on November 22, 2013, provides overview of global IVD market dynamics, discuss growth strategy, and explore early opportunities in the African IVD market. Additionally, a company spotlight is provided for Global BioDiagnostics based in Temple, Texas. The company is focused on developing affordable diagnostic tes...

USD 450.00

USD 337.50 save 25 %

The following Vital Signs presents highlights from our attendance at Health 2.0 in Santa Clara, CA. This meeting is held every fall in the San Francisco area and is considered to be one of the premier events to gage the latest trends in disruptive health IT, particularly related to consumer health and patient engagement. We discuss our perspectives...

USD 450.00

USD 337.50 save 25 %

This issue of Vital Signs, released on October 31, 2013, discusses perspectives of different Frost & Sullivan analysts on recent noteworthy news items for various markets including Pharma/Biotech, In Vitro Diagnostics, and Advanced Medical Technology.

USD 450.00

USD 337.50 save 25 %

This issue of Vital Signs, released on October 31, 2013, provides a review of the radiology reporting market transition to technology-based solutions. Radiology reporting is an advancing area in medical imaging informatics. Additionally, a company spotlight is provided for Montage Healthcare Solutions. The company developed Montage Search and An...

USD 450.00

USD 337.50 save 25 %

Given the importance of the changes from PPACA and the creation of the health insurance marketplaces, we are providing our online Frost.com blog on HIX in collected form for the month of September for ease of use by our subscription clients. This discussion is brought to you by our Connected Health research program. Please also follow our blog, par...

USD 450.00

USD 337.50 save 25 %

This issue of Vital Signs, released on September 30, 2013, discusses perspectives of different Frost & Sullivan analysts on recent noteworthy news items for various markets including Pharma/Biotech, In Vitro Diagnostics, Advanced Medical Technology and Connected Health.

USD 450.00

USD 337.50 save 25 %

This issue of Vital Signs, released on September 30, 2013, provides a market overview and drug pipeline analysis of Type 2 diabetes therapeutics. Additionally, a company spotlight is provided for Trovagene in San Diego, CA. The company has a proprietary transrenal nucleic acid platform with the potential to deliver superior molecular diagnostics i...

USD 450.00

USD 337.50 save 25 %

Given the importance of the changes from PPACA and the creation of the health insurance marketplaces, we are providing our online Frost.com blog on HIX in collected form for the month of August for ease of use by our subscription clients. This discussion is brought to you by our Connected Health research program. Please also follow our blog, part o...

USD 450.00

USD 337.50 save 25 %

The following Vital Signs presents analyst perspectives from our attendance at ACE 2013. The Allscripts Client Experience (ACE) is the companys annual user conference, held this year in Chicago, August 21-23. It offers registrants access to educational sessions, networking opportunities and more. During the event, Allscripts shows clients how to g...

USD 450.00

USD 337.50 save 25 %

Showing 1-10 of 14